KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurora Cannabis (ACB) Cash & Equivalents (2018 - 2025)

Historic Cash & Equivalents for Aurora Cannabis (ACB) over the last 8 years, with Q4 2025 value amounting to $40.4 million.

  • Aurora Cannabis' Cash & Equivalents fell 5741.95% to $40.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $40.4 million, marking a year-over-year decrease of 5741.95%. This contributed to the annual value of $96.1 million for FY2025, which is 483.03% down from last year.
  • Latest data reveals that Aurora Cannabis reported Cash & Equivalents of $40.4 million as of Q4 2025, which was down 5741.95% from $69.5 million recorded in Q3 2025.
  • In the past 5 years, Aurora Cannabis' Cash & Equivalents registered a high of $371.5 million during Q1 2021, and its lowest value of $40.4 million during Q4 2025.
  • Its 5-year average for Cash & Equivalents is $199.1 million, with a median of $174.9 million in 2023.
  • Per our database at Business Quant, Aurora Cannabis' Cash & Equivalents surged by 16877.55% in 2021 and then plummeted by 5741.95% in 2025.
  • Aurora Cannabis' Cash & Equivalents (Quarter) stood at $334.4 million in 2021, then dropped by 5.28% to $316.7 million in 2022, then crashed by 45.51% to $172.6 million in 2023, then plummeted by 44.99% to $94.9 million in 2024, then plummeted by 57.42% to $40.4 million in 2025.
  • Its Cash & Equivalents was $40.4 million in Q4 2025, compared to $69.5 million in Q3 2025 and $101.2 million in Q2 2025.